SCHEMBL18845871

SCHEMBL18845871

CC1(C)c2ccccc2-c2c1ccc1c(-c3cccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3)nc3ccccc3c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
ATM Q13315 1/20 0.36
WHR1 P49842 1/20 0.34
CYP1A2 P05177 7/20 0.34
CYP3A4 P08684 7/20 0.34
CYP2D6 P10635 5/20 0.34
CYP2C19 P33261 4/20 0.34
CLK4 Q9HAZ1 4/20 0.34
CYP2C9 P11712 4/20 0.34
HSD17B10 Q99714 3/20 0.34
USP2 O75604 2/20 0.34
MAPK1 P28482 2/20 0.34
ALOX15 P16050 1/20 0.34
NR1I3 Q14994 4/20 0.33
TSHR P16473 3/20 0.33
LMNA P02545 2/20 0.33
CYP2B6 P20813 2/20 0.33
AHR P35869 2/20 0.33
VDR P11473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18846057 0.94 MEN1 (0.34) MEN1KMT2AWHR1CYP1A2CYP3A4
SCHEMBL18845941 0.93 MEN1 (0.34) MEN1KMT2AATMLMNAALDH1A1
SCHEMBL18845710 0.92 ATM (0.44) MEN1KMT2AATMWHR1TSHR
SCHEMBL18845967 0.92 MEN1 (0.41) MEN1KMT2AATMWHR1CYP1A2
SCHEMBL18846054 0.91 MEN1 (0.36) MEN1KMT2AATMCYP1A2CYP2C19
SCHEMBL18845735 0.88 MEN1 (0.38) MEN1KMT2AATMWHR1CYP1A2
SCHEMBL18845806 0.88 MEN1 (0.38) MEN1KMT2AATMWHR1CYP1A2
SCHEMBL18845829 0.88 MEN1 (0.48) MEN1KMT2AATMWHR1CYP1A2
SCHEMBL19530616 0.88 MEN1 (0.37) MEN1KMT2AATMWHR1CYP1A2
SCHEMBL18845930 0.87 MEN1 (0.38) MEN1KMT2AATMWHR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 MEN1 1034/4885KMT2A 579/4885ATM 3417/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 MEN1 1034/4885KMT2A 579/4885ATM 3417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.